Industry Spotlight

Japanese patent for Regeneus’ Progenza

25 May 2017 via Biotech Dispatch: Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, has announced the Japanese Patent Office has issued a decision to grant a key patent covering the composition, manufacture and use of Progenza stem cell technology. ... | READ MORE

Parliamentary hold-up impacts TGA review changes

25 May 2017 via Biotech Dispatch: Implementation of some key changes announced as part of the review of medicines and medical devices regulation will likely be delayed. ; Read more in Biotech Dispatch. | READ MORE

Paradigm welcomes new publication

23 May 2017 via Biotech Dispatch: Paradigm Biopharmaceuticals (ASX:PAR) has announced the peer reviewed publication validating the efficacy of PPS in experimental allergic rhinitis using an industry standard preclinical model. The company welcomed publication in the... | READ MORE

Patient treatment commences in Cynata clinical trial

18 May 2017 via Biotech Dispatch: Australian stem cell and regenerative medicine company, Cynata Therapeutics (ASX:CYP), has announced the first patient has been treated with CYP-001, its first mesenchymal stem cell (MSC) product, in its Phase 1 clinical trial in pat... | READ MORE

Actinogen Medical starts Phase II trial for Alzheimer’s therapy

18 May 2017 via Biotech Dispatch: A promising areas of Alzheimers disease drug research has reached a new milestone, with the recruitment and treatment of the first patient in a Phase II clinical trial of Actinogen Medicals cortisol-blocking drug Xanamem. The patien... | READ MORE

BI extends development of Pharmaxis compound

16 May 2017 via Biotech Dispatch: A major boost for Pharmaxis (ASX:PXS) with Boehringer Ingelheim extending its development of the Sydney-based companys PXS‐4728A. Boehringer Ingelheim acquired PXS‐4728A from Pharmaxis in May 2015 with initial clinical d... | READ MORE

CropLife concern over APVMA performance

16 May 2017 via Biotech Dispatch: CropLife Australia has again expressed concern over the Turnbull governments decision to relocate the Australian Pesticides and Veterinary Medicines Authority (APVMA) from Canberra to Armidale. According to CropLife, performance sta... | READ MORE

Recognition for IDT Australia at manufacturing awards

11 May 2017 via Biotech Dispatch: Boronia-based IDT Australia has won the Growth Sector - Medical Technologies and Pharmaceuticals category award at the 2017 Victorian Manufacturing Hall of Fame. Member for Eastern Metropolitan Region Shaun Leane today congratulated... | READ MORE

MTPConnect welcomes Budget

11 May 2017 via Biotech Dispatch: MTPConnect - the Industry Growth Centre for medical technology, biotechnology and pharmaceutical (MTP) sector - has welcomed this years Budget. “The budget is well positioned to provide major new investments in manufacturing i... | READ MORE

Extended distribution deal for Rhinomed

9 May 2017 via Biotech Dispatch: Respiratory technology company Rhinomed (ASX:RNO) has announced it has been advised by leading Australian pharmacy wholesale distributor, Sigma Healthcare, its Mute sleep technology will form part of the 2017 core range for the Amcal ... | READ MORE

Previous page | Next page
Jump to page